Table 2.
Demographic characteristics of selected study sites
Balochistan | FATA | |
---|---|---|
![]() |
![]() |
|
Population | ||
Area | 347,190 sq. km. | 27,224 sq. km |
Populationa | 12,344,408 | 5,001,676 |
Battle Related Deaths 2000–2017 | 2698 | 23,575 |
Number of Healthcare Facilities | 668b | 201c |
Health Service Coveraged | ||
Use of any modern method of family planning | 14.0 | 13.7 |
% of demand satisfied | 47.9 | 66.4 |
Total Fertility Rate (Births per woman) | 4.0 | 4.8 |
Pregnant women receiving iron folate | 17.1 | 50 |
Last birth protected by Neonatal tetanus | 26.7 | 38.5 |
Skilled birth attendance | 38.2 | 52.1 |
Institutional delivery rate | 34.6 | 49.1 |
PNC within 2 days (mother/newborn) | 37.9 | 31.8 |
BCG | 46.6 | 54.9 |
Three doses of polio vaccine | 57.1 | 82.5 |
Three doses of DPT-HepB-Hib | 40.1 | 46.7 |
Measles immunization coverage | 33.3 | 34.5 |
Full vaccination coverage | 28.8 | 30.4 |
Number of children with symptoms of ARI | 58 | 32 |
Child acute respiratory infection care seeking | 62.2 | 70.6 |
Child fever care seeking | 60 | 62.9 |
Children with diarrhea | 95 | 48 |
Children with diarrhea treated with ORS | 51 | 23.9 |
Key: a: Pakistan census 2017; b: Health Facility Assessment – Balochistan Provincial Report 2012; c: Health Facility Assessment – FATA Provincial Report 2012; d: Pakistan Demographic Survey 2017–2018
PNC Post natal care, BCG Bacille Calmette-Guérin, ARI Acute respiratory infection), ORS Oral Rehydration Solution